B. Goldlust

Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjögren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. P92-01 Study Group.

F. Vivino, I. Al-Hashimi, F. Leveque, 1999, Archives of internal medicine.

Successful Treatment of Dry Mouth and Dry Eye Symptoms in Sjögren's Syndrome Patients With Oral Pilocarpine: A Randomized, Placebo-Controlled, Dose-Adjustment Study

T. Medsger, M. Charney, A. Papas, 2004, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

Reduced risk of NSAID gastropathy (GI mucosal toxicity) with nonacetylated salicylate (salsalate): an endoscopic study.

S. Roth, B. Ekholm, E. Lee, 1990, Seminars in arthritis and rheumatism.

An endoscopic comparison of the gastroduodenal injury seen with salsalate and naproxen.

F. Lanza, M. Rack, B. Ekholm, 1989, The Journal of rheumatology.

Comparison of the effects of immediate‐release omeprazole powder for oral suspension and pantoprazole delayed‐release tablets on nocturnal acid breakthrough in patients with symptomatic gastro‐oesophageal reflux disease

R. Bagin, D. Castell, B. Goldlust, 2005, Alimentary pharmacology & therapeutics.

Comparative effects of an omeprazole antacid complex-immediate release (OAC-IR) and omeprazole-delayed release (OME-DR) on omeprazole pharmacokinetics (PK) and gastric pH in healthy subjects

B. Goldlust, B. Hepburn, 2003 .

NIGHTTIME DOSING OF OMEPRAZOLE IMMEDIATE-RELEASE ORAL SUSPENSION RAPIDLY DECREASES NOCTURNAL GASTRIC ACIDITY: 116

B. Goldlust, B. Hepburn, Yun J Hardiman, 2004 .

Developing nonsteroidal anti-inflammatory drugs (NSAIDs) with decreased gastrointestinal (GI) toxicity.

B. Goldlust, M. Doucette, C. Verduyn, 1991, Agents and actions. Supplements.

Does the acetyl group of aspirin contribute to the antiinflammatory efficacy of salicylic acid in the treatment of rheumatoid arthritis?

S. Cohen, M. Abeles, H. Baraf, 1990, Seminars in arthritis and rheumatism.